A Phase 1b Study of PU-H71 With Nab-paclitaxel (Abraxane) in Patients With HER2-Negative Metastatic Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 30 May 2017
At a glance
- Drugs PU H71 (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Adverse reactions
- 23 May 2017 Status changed from planning to recruiting.
- 06 Apr 2017 New trial record
- 30 Mar 2017 According to a Samus Therapeutics media release, the company expects to initiate this trial in early second quarter of 2017.